2024-09-10 - Analysis Report
##  JNJ Stock Analysis Report

**Company Overview:** Johnson & Johnson is a multinational pharmaceutical, medical device, and consumer packaged goods conglomerate. 

**Performance Summary:**

1. **Relative Performance:** JNJ has underperformed the S&P 500 (VOO) over the period analyzed. The cumulative return for JNJ is 18.69%, while the S&P 500 has gained 81.34%. This results in a negative divergence of -62.65%, which is in the 20.28th percentile of historical divergence.

2. **Recent Price Movements:**  JNJ is currently trading at $164.38. The stock is above its 5-day moving average ($165.95) but below its 20-day ($162.45) and 60-day ($155.45) moving averages, suggesting a potential short-term downward trend.

3. **Technical Indicators:**
    * **RSI (67.48):** JNJ is currently in the overbought territory, indicating potential for a correction.
    * **PPO (-0.02):** The PPO is slightly negative, indicating a minor bearish signal.
    * **Delta_Previous_Relative_Divergence (0.12):** The slight positive value suggests a possible short-term uptrend in the stock's relative performance.
    * **Expected Return (10.93%):** This suggests a potential for a 10.93% return over the next 5 years, based on current investment levels.

4. **Recent Earnings and Outlook:**
    * **Latest Earnings (2024-07-25):** 
        * **EPS:** $1.95 (Actual) 
        * **Revenue:** $22.45 Billion (Actual)
    * **Analysis:** The latest earnings results were above analyst expectations, indicating strong performance. 

**Overall Analysis:**

JNJ currently exhibits a mixed picture. While the company shows strong recent earnings, its stock price has underperformed the market and is currently showing potential bearish technical indicators. It's crucial to monitor the stock's future performance and its response to the latest earnings report before making any investment decisions.

**Disclaimer:** This analysis is provided for informational purposes only and should not be considered as financial advice. It is essential to conduct thorough research and consult with a qualified financial advisor before making any investment decisions.